Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Acquisitions Help Strides Back Into Black

This article was originally published in PharmAsia News

Executive Summary

Indian drug maker Strides Arcolab, which is aiming to build a global business-to-customer operation driven by its own product pipeline, swung to a net profit in the second financial quarter from a year ago, propelled by strong across-the-board sales momentum following a string of acquisitions. It is now looking at "very good growth from its combined assets."

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC088472

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel